Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 2
2022 5
2023 2
2024 1
2025 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Cited In for PMID: 33865615

11 results

Results by year

Filters applied: . Clear all
Page 1
Quality of Life in Adult and Pediatric Patients with Tropomyosin Receptor Kinase Fusion Cancer Receiving Larotrectinib.
Kummar S, Berlin J, Mascarenhas L, van Tilburg CM, Geoerger B, Lassen UN, Schilder RJ, Turpin B, Nanda S, Keating K, Childs BH, Chirila C, Laetsch TW, Hyman DM, Drilon A, Hong DS. Kummar S, et al. Curr Probl Cancer. 2021 Dec;45(6):100734. doi: 10.1016/j.currproblcancer.2021.100734. Epub 2021 Apr 2. Curr Probl Cancer. 2021. PMID: 33865615 Free article. Clinical Trial.
Neurotrophic tyrosine receptor kinase gene fusions in adult and pediatric patients with solid tumors: a clinicogenomic biobank and record linkage study of expression frequency and patient characteristics from Finland.
Zhang W, Schmitz AA, Kallionpää RE, Perälä M, Pitkänen N, Tukiainen M, Alanne E, Jöhrens K, Schulze-Rath R, Farahmand B, Zong J. Zhang W, et al. Acta Oncol. 2024 Jul 5;63:542-551. doi: 10.2340/1651-226X.2024.26452. Acta Oncol. 2024. PMID: 38967220 Free PMC article.
TrkA Co-Receptors: The Janus Face of TrkA?
Trouvilliez S, Lagadec C, Toillon RA. Trouvilliez S, et al. Cancers (Basel). 2023 Mar 23;15(7):1943. doi: 10.3390/cancers15071943. Cancers (Basel). 2023. PMID: 37046604 Free PMC article. Review.
Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers.
Le X, Baik C, Bauman J, Gilbert J, Brose MS, Grilley-Olson JE, Patil T, McDermott R, Raez LE, Johnson JM, Shen L, Tahara M, Ho AL, Norenberg R, Dima L, Brega N, Drilon A, Hong DS. Le X, et al. Oncologist. 2022 May 10;29(6):e779-88. doi: 10.1093/oncolo/oyac080. Online ahead of print. Oncologist. 2022. PMID: 35536733 Free PMC article.
Diagnosis and management of TRK fusion cancer.
Kummar S, Italiano A, Brose MS, Carlson JJ, Sullivan SD, Lassen U, Federman N. Kummar S, et al. Am J Manag Care. 2022 Jan;28(2 Suppl):S15-S25. doi: 10.37765/ajmc.2022.88834. Am J Manag Care. 2022. PMID: 35201680 Free PMC article. Review.
11 results